The Local Empowerment for Advocacy Development (LEAD) Program is a novel program that CSL Behring's partnerships with local patient organizations on the state level. CSL Behring believes that successful advocacy results from the empowerment of those that are impacted by a particular issue. For example, public policies that affect the users of plasma-derived and recombinant therapies are now typically being developed at the state level; therefore, local organizations need to develop the capability to address this pressing need.
CSL Behring recognizes that many local patient advocacy organizations need to expand their advocacy capabilities in order to address both present and future needs. CSL Behring’s LEAD Program assists local advocacy organizations in the development of their advocacy capabilities.
The program has two specific initiatives: